document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align right text omitted filed separately with style margin margin bottom font size font family time roman align right security exchange commission style margin margin bottom font size font family time roman align right confidential treatment requested under style margin margin bottom font size font family time roman align right nbsp section style margin margin bottom font size font family time roman align center collaboration license agreement style margin margin bottom text indent font size font family time roman align justify small small small ollaboration small small small small icense small small greement small small small agreement entered into march nbsp effective date between small eurocrine small small iosciences small small small delaware corporation neurocrine having address camino real diego small itsubishi small small anabe small small harma small small orporation small small small corporation organized under japan mtpc having address kitahama chome chuo osaka japan neurocrine mtpc referred herein individually party collectively party style margin margin bottom font size font family time roman align center small ecitals small style margin margin bottom text indent font size font family time roman align justify small hereas small small small neurocrine developing proprietary compound referred owns control certain patent know other intellectual property relating such compound style margin margin bottom text indent font size font family time roman align justify small hereas small small small mtpc engaged research development commercialization pharmaceutical product style margin margin bottom text indent font size font family time roman align justify small hereas small small small mtpc desire obtain from neurocrine neurocrine desire grant mtpc exclusive license develop register import manufacture commercialize product containing japan china other asian country subject term condition this agreement style margin margin bottom font size font family time roman align center small greement small style margin margin bottom text indent font size font family time roman align justify small small small herefore small small small consideration foregoing premise mutual covenant contained herein other good valuable consideration receipt sufficiency which hereby acknowledged neurocrine mtpc hereby agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size nbsp nbsp small efinitions small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp affiliate mean with respect party entity that directly indirectly through more intermediary control controlled under common control with such party only long such control exists used this section nbsp control mean nbsp posse directly indirectly power direct management policy entity whether through ownership voting security contract relating voting right corporate governance nbsp direct indirect beneficial ownership more than fifty percent nbsp voting share capital other equity interest such entity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp alliance manager meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp applicable mean applicable provision national supranational regional state local treaty statute rule regulation administrative code guidance ordinance judgment decree directive injunction order permit including maas from court arbitrator regulatory authority governmental agency authority having jurisdiction over related subject item style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp calendar quarter mean each respective period three nbsp consecutive month ending march nbsp june nbsp september nbsp december nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp calendar year mean each respective period twelve nbsp consecutive month ending december style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp mean chemistry manufacturing control style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp mean contract manufacturing organization style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercialization mean conduct activity undertaken before after regulatory approval relating promotion marketing sale distribution including importing exporting transporting custom clearance warehousing invoicing handling delivering product customer product field outside mtpc territory including nbsp sale force effort detailing advertising medical education planning marketing sale force training sale distribution nbsp scientific medical affair nbsp post approval clinical trial commercialize commercializing have correlative meaning style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercialization plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp commercialization strategy meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp commercially reasonable effort mean with respect mtpc obligation under this agreement with respect compound product those effort resource that consistent with exercise customary scientific business practice applied pharmaceutical industry development regulatory commercialization activity conducted with respect product similar stage development commercialization having similar commercial potential taking into account relative safety efficacy product profile competitiveness marketplace market potential such product nature extent market exclusivity including patent coverage regulatory data protection price reimbursement status commercially reasonable effort requires that mtpc nbsp promptly assign responsibility each such obligation specific employee held accountable progress monitor such progress ongoing basis nbsp seek achieve specific meaningful objective carrying such obligation nbsp make implement decision allocate resource designed advance progress with respect such objective style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp committee mean subcommittee established applicable style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp compound mean nbsp valbenazine referred neurocrine having chemical structure forth letter agreement nbsp other compound derivative valbenazine that claimed patent existing effective date included list patent attached letter agreement style margin margin bottom text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp compound invention meaning forth section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp confidential disclosure agreement mean that certain confidential disclosure agreement between neurocrine mtpc dated march nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp confidential information mean know other proprietary scientific marketing financial commercial information data that generated behalf party affiliate which party affiliate supplied otherwise made available other party affiliate whether made available orally writing electronic form including information comprising relating concept discovery invention data design formula relation this agreement provided that neurocrine technology will deemed neurocrine confidential information mtpc technology will deemed mtpc confidential information joint invention joint patent will deemed both party confidential information style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mean third party company contracted with either party manufacture engage manufacturing activity compound product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp control controlled mean with respect know patent other intellectual property right legal authority right whether ownership license otherwise without taking into account right granted party other party pursuant this agreement party grant access license sublicense under such know patent other intellectual property right another party otherwise disclose proprietary trade secret information such other party without breaching term agreement with third party misappropriating proprietary trade secret information third party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp cost good mean with respect compound product fully burdened cost expense manufacture supply such compound product which mean nbsp case product service acquired from third party including quality control quality assurance service payment made such third party nbsp case manufacturing service performed party affiliate including manufacturing service support product service acquired from third party contemplated subsection actual unit cost manufacture plus variance other cost specifically provided herein actual unit cost shall consist style font size vertical align calculated accordance with gaap direct material cost shall include cost incurred direct style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify labor cost shall include cost nbsp nbsp nbsp style font size vertical align manufacturing overhead attributable such compound product shall include style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp data mean scientific technical test marketing sale data pertaining compound product that generated behalf mtpc affiliate sublicensees behalf neurocrine affiliate extent controlled neurocrine neurocrine collaborator including research data clinical pharmacology data data including analytical manufacturing quality control data stability data clinical data clinical data submission made association with with respect compound product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp develop mean develop including clinical clinical development analyze test conduct preclinical clinical other regulatory trial compound product well related regulatory activity activity pertaining indication pharmacokinetic study related activity including work formulation method treatment activity including manufacturing method developing development have correlative meaning style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp development plan meaning forth section nbsp initial development plan attached letter agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp drug product meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mean european union style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp excluded claim meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp executive officer meaning forth section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp export control mean applicable regulation relating nbsp sanction embargo imposed office foreign asset control department treasury nbsp export export commodity technology service including export administration international emergency economic power trading with enemy export control international boycott provision section nbsp internal revenue code amended style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp fcpa mean foreign corrupt practice section nbsp amended anti bribery applicable local anti bribery regulation style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp field mean treatment management prophylaxis diagnosis disease human style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp first commercial sale mean product product country country basis first sale mtpc affiliate sublicensees neurocrine affiliate neurocrine collaborator case third party consumption product given country outside mtpc territory respectively after regulatory approval been granted with respect such product such country sale product party affiliate sublicensee licensee shall constitute first commercial sale unless there subsequent resale such product such affiliate sublicensee licensee style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp gaap mean generally accepted accounting principle applicable country jurisdiction consistently applied mean international financial reporting standard ifrs such time ifrs becomes generally accepted accounting standard applicable require that party ifrs style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp generic product mean with respect product particular regulatory jurisdiction pharmaceutical product that nbsp nbsp contains same active pharmaceutical ingredient such product same formulation dosage form such product same route administration such product approved regulatory authority such country indication which such product obtained regulatory approval from applicable regulatory authority such jurisdiction nbsp approved regulatory authority such country substitutable generic such product indication which such product obtained regulatory approval from applicable regulatory authority such jurisdiction expedited abbreviated basis manner that relied incorporated data submitted mtpc affiliate sublicensee connection with regulatory approval product such jurisdiction nbsp sold such jurisdiction third party that sublicensee purchase such product chain distribution that included mtpc affiliate sublicensees style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp global trial mean clinical trial designed obtain data used support filing obtaining regulatory approval product field both nbsp japan either nbsp avoidance doubt global trial include trial style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp governmental authority mean national international federal state provincial local government political subdivision thereof multinational organization authority agency commission entitled exercise administrative executive judicial legislative police regulatory taxing authority power court tribunal department bureau division thereof governmental arbitrator arbitral body style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mean chorea associated with huntington disease style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp trial mean clinical trial product conducted neurocrine neurocrine collaborator support filing obtaining regulatory approval product style font size vertical align forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp rule meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mean international conference harmonization technical requirement registration pharmaceutical human style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mean investigational drug application equivalent application filed with applicable regulatory authority which application required commence human clinical trial applicable country style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp initiation mean with respect clinical trial first dosing first subject such clinical trial style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp invention mean invention whether patentable discovered made conceived conceived reduced practice course activity contemplated this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp joint compound improvement invention mean invention discovered made conceived conceived reduced practice after effective date during term this agreement jointly nbsp more employee contractor mtpc affiliate nbsp more employee contractor neurocrine which relate manufacture formulation composition compound style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp joint invention mean invention discovered made conceived conceived reduced practice jointly nbsp more employee contractor mtpc affiliate nbsp more employee contractor neurocrine excluding compound invention mtpc compound improvement invention joint compound improvement invention after effective date during term this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp joint patent mean patent extent claim joint invention style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp meaning forth section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp know mean technical information know data including invention discovery trade secret specification instruction process formula composition matter cell cell line assay animal model other physical biological chemical material expertise other technology applicable formulation composition style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify product their manufacture development registration marketing method assaying testing them process their manufacture formulation containing them composition incorporating comprising them including biological chemical pharmacological biochemical toxicological pharmaceutical physical analytical safety quality control manufacturing nonclinical clinical data regulatory document data filing instruction process formula expertise information relevant research development manufacture importation offering sale sale which useful studying testing developing producing formulating product intermediate synthesis thereof know excludes patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp letter agreement mean that certain letter agreement even date herewith between neurocrine mtpc including exhibit thereto style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp loss meaning forth section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mean marketing authorization application equivalent application amendment supplement thereto filed with applicable regulatory authority country jurisdiction style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp manufacture manufacturing shall mean activity required manufacture compound product neurocrine itself through affiliate including test method development stability testing formulation development process development manufacturing scale process validation manufacturing starting material quality assurance quality control style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp material meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mhlw mean ministry health labour welfare successor agency thereto having administrative authority regulate marketing human pharmaceutical product biological therapeutic product japan style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp milestone event mean event identified section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp milestone payment mean payment identified section nbsp made mtpc neurocrine occurrence milestone event style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mtpc compound improvement invention mean invention discovered made conceived conceived reduced practice after effective date during term this agreement solely nbsp more employee contractor mtpc affiliate which relate manufacture formulation composition compound style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mtpc data meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mtpc indemnitee meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mtpc know mean know that mtpc affiliate control effective date during term including joint invention that necessary reasonably useful research development manufacture importation offer sale sale compound product field mtpc font style white space nowrap know font includes mtpc data style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mtpc patent mean patent that mtpc affiliate control effective date during term that would infringed absent license other right practice granted under such patent research development manufacture importation offer sale sale compound product field considering patent application issued with then pending claim style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mtpc technology mean mtpc know mtpc patent including mtpc interest joint invention joint patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mtpc territory mean japan south korea taiwan china indonesia singapore malaysia lanka thailand vietnam hong kong pakistan philippine myanmar brunei style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp sale mean with respect product style font size vertical align following deduction with respect sale other disposition such product style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style margin margin bottom text indent font size font family time roman align justify such amount shall determined accordance with gaap consistently applied style margin margin bottom text indent font size font family time roman align justify upon sale other disposition product that should included within sale consideration other than exclusively monetary consideration bona fide style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify length term then purpose calculating sale under this agreement such product shall deemed sold exclusively money style font size vertical align style margin margin bottom text indent font size font family time roman align justify event will particular amount identified above deducted more than once calculating sale sale product between mtpc affiliate sublicensees resale shall excluded from computation sale subsequent resale such product third party that sublicensee shall included within computation sale style margin margin bottom text indent font size font family time roman align justify mtpc affiliate sublicensees shall sell product combination with part bundle with other product offer packaged arrangement customer that include product such manner disproportionately discount selling price product compared with weighted average discount applied other product percent respective list price available good faith estimate thereof such product product prior applying discount style margin margin bottom text indent font size font family time roman align justify event product sold part combination product defined below sale from combination product purpose determining royalty payment shall determined multiplying sale combination product during applicable royalty reporting period fraction case style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp neurocrine collaborator mean third party licensee neurocrine with respect development commercialization compound product country outside mtpc territory style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp neurocrine data meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp neurocrine indemnitee meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp neurocrine know mean know that neurocrine control effective date during term including joint invention that nbsp necessary reasonably useful research development manufacture testing importation offer sale sale compound product field mtpc territory neurocrine font style white space nowrap know font includes neurocrine data clarity neurocrine font style white space nowrap know font includes know data neurocrine that nbsp necessary reasonably useful manufacture compound product provided such know neurocrine possession neurocrine legal right transfer such know style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp neurocrine patent mean patent mtpc territory that neurocrine control effective date during term that would infringed absent license other right practice granted under such patent research development manufacture style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify importation offer sale sale compound product field mtpc territory considering patent application issued with then pending claim neurocrine patent existing effective date forth list attached letter agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp neurocrine technology mean neurocrine font style white space nowrap know font information manufacturing neurocrine patent including neurocrine interest joint invention joint patent mtpc compound improvement invention joint compound improvement invention style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp patent mean nbsp national regional international patent certificate invention application certificate invention priority patent filing patent application nbsp renewal division continuation whole part request continued examination such patent certificate invention patent application patent certificate invention issuing thereon reissue reexamination extension division renewal substitution confirmation registration revalidations revision addition foregoing style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp phase nbsp clinical trial mean clinical trial country conducted small number human volunteer designed intended establish initial safety profile pharmacodynamics pharmacokinetics compound product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp phase nbsp clinical trial mean clinical trial compound product human patient country determine initial efficacy dose range finding before embarking phase nbsp clinical trial style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp phase nbsp clinical trial mean pivotal clinical trial compound product human patient country with defined dose defined product designed ascertain efficacy safety such compound product purpose submitting application regulatory approval competent regulatory authority style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp pmda mean pharmaceutical medical device agency successor thereto style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp pricing reimbursement approval mean with respect product approval agreement determination decision regulatory authority establishing price level reimbursement such product required given country jurisdiction prior sale such product such jurisdiction style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp product mean pharmaceutical product containing compound active ingredient alone combination with nbsp more other active pharmaceutical ingredient combination product dosage form formulation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp public official entity mean nbsp officer employee including physician hospital administrator other healthcare professional agent representative department agency facto official representative corporate entity instrumentality subdivision government military international governmental organization including ministry department health state owned affiliated company hospital nbsp candidate political office political party official political party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp regulatory approval mean approval license registration permit notification authorization waiver regulatory authority that necessary manufacture storage import transport promotion marketing distribution offer sale sale other commercialization product country jurisdiction style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp regulatory authority mean governmental authority that responsibility applicable jurisdiction over testing development manufacture storage import transport promotion marketing distribution offer sale sale other commercialization pharmaceutical product given jurisdiction including mhlw pmda japan country where governmental approval required pricing reimbursement pharmaceutical product reimbursed national health insurance local equivalent regulatory authority shall also include governmental authority whose review approval pricing reimbursement such product required style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp regulatory filing mean application filing submission approval license registration permit notification authorization waiver with respect testing development manufacture commercialization compound product made received from regulatory authority given country including inds maas style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp royalty term meaning forth section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp safety data mean data related solely adverse drug experience serious adverse drug experience such information reportable regulatory authority outside mtpc territory safety data also includes adverse event adverse drug reaction unexpected adverse drug reaction defined harmonised tripartite guideline clinical safety data management definition standard expedited reporting style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mean security exchange commission successor entity style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp sublicensee mean third party whom mtpc grant sublicense research develop make have made import promote offer sale sell compound product field mtpc territory either independently from cooperation with mtpc beyond mere right purchase product from mtpc affiliate event shall neurocrine affiliate deemed sublicensee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp supply agreement meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp withholding avoidance document meaning forth section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mean neuroleptic induced dopamine receptor antagonist induced tardive dyskinesia style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp term meaning forth section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp third party mean entity other than neurocrine mtpc affiliate neurocrine mtpc style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp mean united state america including territory possession district columbia style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp valid claim mean nbsp claim issued unexpired patent that been revoked held unenforceable unpatentable invalid decision court other governmental agency competent jurisdiction that appealable been appealed within time allowed appeal that been abandoned disclaimed denied admitted invalid unenforceable through reissue examination disclaimer otherwise nbsp claim pending patent application that been cancelled withdrawn abandoned finally rejected administrative agency action from which appeal taken style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small rant small small small small icenses small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license granted mtpc subject term condition this agreement neurocrine hereby grant mtpc during term style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp exclusive even neurocrine except expressly forth herein royalty bearing license with right grant sublicenses provided section nbsp under neurocrine technology research develop make have made import compound product field mtpc territory promote offer sale sell product field mtpc territory which license includes right nbsp incorporate neurocrine data regulatory filing with regulatory authority mtpc territory commercialization material nbsp cross reference regulatory filing controlled neurocrine outside mtpc territory each case nbsp nbsp solely purpose nbsp obtaining regulatory approval product field mtpc territory nbsp supporting commercialization activity style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp exclusive royalty bearing license with right grant sublicenses provided section nbsp under neurocrine technology make have made compound style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify product outside mtpc territory solely purpose exercising license granted section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp sublicenses mtpc shall have right grant sublicenses under license granted section nbsp nbsp affiliate with prior written notice neurocrine nbsp third party mtpc territory with prior written consent neurocrine which consent shall made denied neurocrine within mtpc written request otherwise such consent shall deemed have been given solely purpose exercising license granted section nbsp sublicenses granted under license granted section nbsp shall writing shall subject consistent with term condition this agreement mtpc shall ensure that each agreement with sublicensee grant neurocrine right with respect data invention regulatory filing made generated such sublicensee such data invention regulatory filing were made generated mtpc mtpc shall responsible compliance affiliate sublicensees with term condition this agreement when mtpc request neurocrine consent sublicense mtpc shall provide neurocrine with full complete copy such sublicense agreement mtpc redact from copy sublicense agreement financial term other condition therein which shall necessary verify compliance with term condition this agreement within after entering into such sublicense mtpc shall deliver fully executed redacted copy agreement neurocrine style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license granted neurocrine subject term condition this agreement mtpc hereby grant neurocrine style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp exclusive even mtpc except expressly forth herein extent permitted country mtpc territory other than japan royalty free fully paid irrevocable perpetual license with right sublicense through multiple tier under mtpc technology research develop make have made import compound product field outside mtpc territory promote sell offer sale product field outside mtpc territory which license includes right nbsp incorporate mtpc data regulatory filing with regulatory authority outside mtpc territory nbsp cross reference regulatory filing controlled mtpc mtpc territory each case solely purpose obtaining regulatory approval product field outside mtpc territory style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp exclusive royalty free fully paid irrevocable perpetual license with right sublicense through multiple tier under mtpc technology make have made compound product mtpc territory solely purpose exercising license granted section nbsp reserved right section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp reserved right neurocrine hereby expressly reserve nbsp right practice grant license under neurocrine technology outside scope license granted section nbsp purpose nbsp right conduct activity conducted neurocrine contemplated this agreement including activity under development plan contemplated supply agreement nbsp exclusive right make have made compound product mtpc territory purpose researching developing making having made using exporting compound product style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify field outside mtpc territory promoting selling offering sale product field outside mtpc territory subject only right expressly granted under section nbsp mtpc hereby expressly reserve right practice grant license under mtpc technology purpose style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp implied license negative covenant except forth this agreement neither party shall acquire license other intellectual property interest implication otherwise under patent know other intellectual property owned controlled other party neither party shall shall permit affiliate sublicensees practice patent know licensed other party outside scope license granted under this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp disclosure know neurocrine shall without additional compensation disclose make available mtpc whatever form mtpc reasonably request including providing copy thereof neurocrine know nbsp that existence effective date promptly after effective date nbsp that come into existence after effective date that previously provided mtpc promptly after earlier development making conception reduction practice such neurocrine know mtpc shall shall cause affiliate without additional compensation disclose make available neurocrine whatever form neurocrine reasonably request including providing copy thereof mtpc know previously provided neurocrine promptly after earlier development making conception reduction practice such mtpc know style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp data access agreement entered into neurocrine after effective date with neurocrine collaborator such neurocrine collaborator involved generation data neurocrine shall commercially reasonable effort require that such neurocrine collaborator allow neurocrine provide mtpc access right such data generated such neurocrine collaborator without additional compensation extent that such data reasonably useful development commercialization compound product field mtpc territory including preparation filing maas product with applicable regulatory authority mtpc territory accordance with this agreement neurocrine unable after using commercially reasonable effort require that such neurocrine collaborator allow neurocrine provide mtpc access such data generated such neurocrine collaborator then notwithstanding section nbsp neurocrine shall have right provide grant sublicense with respect mtpc data such neurocrine collaborator notwithstanding foregoing neurocrine shall require each neurocrine collaborator allow neurocrine provide mtpc access right data related compound product that nbsp safety data nbsp otherwise necessary provided regulatory authority mtpc territory connection with development commercialization compound product field mtpc territory shall only provide such neurocrine collaborator that mtpc data that either nbsp safety data nbsp otherwise necessary provided regulatory authority outside style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify mtpc territory connection with development commercialization compound product field outside mtpc territory style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small overnance small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint steering committee promptly after effective date party shall establish joint steering committee joint steering committee composed equal number senior officer each party initially three nbsp oversee guide strategic direction collaboration party under this agreement shall particular style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size style font size vertical align table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint development committee promptly after effective date party shall establish joint development committee joint development committee composed three nbsp representative each party review discus development compound product field mtpc territory applicable pursuant section nbsp outside mtpc territory purpose regulatory approval mtpc territory operational level each representative shall have knowledge expertise clinical development product similar product shall particular style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size style font size vertical align table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint commercialization committee time determined event later than commencement first filing mtpc territory party shall establish joint commercialization committee joint commercialization committee composed three nbsp representative each party monitor discus commercialization product field operational level each representative shall have knowledge expertise commercialization product similar product shall particular style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align justify style font family time roman font size table style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp committee membership meeting style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp committee member each committee representative shall have appropriate knowledge expertise sufficient seniority within applicable party make decision arising within scope applicable committee responsibility each party replace representative committee written notice other party each party shall strive maintain continuity representation committee member each party shall appoint nbsp representative each committee chairperson such committee chairperson shall jointly prepare circulate agenda committee member least style font size vertical align before each committee meeting shall direct preparation reasonably detailed minute each committee meeting which shall approved chairperson circulated committee member within such meeting style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp meeting each committee shall hold meeting such time elect event shall such meeting held frequently than once every unless otherwise agreed party upon reasonable written request party hold meeting both party agree schedule such meeting within reasonable time frame meeting committee held person audio video teleconference provided that unless otherwise agreed both party least each committee shall held person person committee shall held location alternately selected party each party shall responsible expense participating committee meeting action taken meeting committee shall effective unless least representative each party participating style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp member attendance each party from time time invite reasonable number participant addition representative attend committee meeting font style white space nowrap voting font capacity provided that either party intends have third party including consultant attend such meeting such party shall provide least prior written notice other party obtain other party approval such third party attend such meeting which approval shall unreasonably withheld delayed such party shall ensure that such third party bound confidentiality obligation consistent with term this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp decision making decision each committee shall made unanimous vote with each party representative collectively having nbsp vote after reasonable discussion good faith consideration each party view particular matter before another subcommittee representative party reach agreement such matter within after such matter brought such committee resolution such disagreement shall referred resolution after reasonable discussion good faith consideration each party view particular matter before representative party reach agreement such matter within after such matter brought resolution after such matter been referred such disagreement shall referred chief executive officer neurocrine chief executive officer mtpc designee collectively executive officer resolution follows style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp then executive officer shall discus good faith resolution matter that address both mtpc objective neurocrine concern worldwide development commercialization product executive officer resolve such matter within after such matter been referred them chief executive officer shall entitled make final decision provided that such decision shall made good faith style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp then executive officer shall discus good faith resolution matter executive officer resolve such matter within after such matter been referred them chief executive officer shall entitled make final decision provided that such decision shall made good faith style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp limitation authority each committee shall have only such power expressly assigned this agreement such power shall subject term condition this agreement without limiting generality foregoing committee will have power amend this agreement decision committee contravention term condition this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp withdrawal time during term reason neurocrine shall have right withdraw from participation committee upon written notice mtpc which notice shall effective immediately upon receipt withdrawal notice following issuance withdrawal notice subject this section nbsp neurocrine representative applicable committee shall participate meeting such committee time following issuance withdrawal notice neurocrine wish resume participation applicable committee neurocrine shall notify mtpc writing thereafter neurocrine representative such committee shall entitled attend subsequent meeting such committee participate activity decision making such committee provided this article withdrawal notice been issued neurocrine following neurocrine issuance withdrawal notice unless until neurocrine resume participation applicable committee accordance with this section nbsp nbsp meeting applicable committee will held mtpc facility nbsp neurocrine shall have right continue receive minute such committee meeting shall have right approve minute meeting such committee held after neurocrine issuance withdrawal notice style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp alliance manager promptly after effective date each party shall appoint individual alliance manager such party alliance manager each alliance manager shall responsible alliance management between party basis throughout term each alliance manager shall permitted attend meeting other committee appropriate voting participant alliance manager style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify shall primary contact party regarding activity contemplated this agreement shall facilitate such activity hereunder each party replace alliance manager with alternative representative time with prior written notice other party alliance manager designate substitute temporarily perform function that alliance manager each alliance manager shall charged with creating maintaining collaborative work environment within subcommittee style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small evelopment small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp development responsibility style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp development mtpc territory subject term condition this agreement mtpc itself with affiliate sublicensees applicable shall responsible sole cost expense development compound product including clinical trial formulation study regulatory activity that necessary otherwise support obtaining maintaining regulatory approval solely mtpc territory mtpc reasonably request that neurocrine conduct assist mtpc with certain such development activity mtpc behalf neurocrine agrees conduct assist with such activity party shall amend development plan accordingly mtpc shall reimburse reasonable internal fully burdened rate external cost incurred neurocrine conduct such activity accordance with development plan provided that item cost such development activity shall discussed agreed upon advance between party clarity such development activity which mtpc request neurocrine itself through affiliate conduct shall include manufacturing activity which required regulatory approval solely mtpc territory style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp development outside mtpc territory subject section nbsp neurocrine itself with affiliate neurocrine collaborator applicable shall responsible sole cost expense development compound product that support obtaining maintaining regulatory approval outside mtpc territory neurocrine itself through affiliate neurocrine collaborator conduct such activity sole discretion style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp development plan mtpc shall conduct development compound product field mtpc territory accordance with comprehensive development plan amended accordance with this agreement development plan initial version which been agreed party attached letter agreement development plan will include development product mtpc territory unless development either such indication terminated accordance with term this agreement party intend that development plan will include detailed description each clinical trial described therein including design enrollment criterion endpoint protocol thereof well regulatory strategy product throughout mtpc territory mtpc will include such information development plan when available from time time least mtpc will update development plan submit such updated plan review discussion will then submit development plan review discussion approval style font size vertical align style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint development style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp trial party acknowledge that patient recruitment clinical trial necessary regulatory approval product japan unreasonably difficult that might best interest commercialization product mtpc territory instead data from trial obtain such regulatory approval promptly after effective date mtpc shall consult with pmda with respect design enrollment criterion clinical trial necessary obtain regulatory approval product japan mtpc shall promptly notify neurocrine outcome such consultation neurocrine mtpc shall discus good faith mutually agree study design protocol cost trial prior initiation trial neurocrine neurocrine shall initiate trial later than mtpc shall update development plan include trial according consultation neurocrine neurocrine shall conduct cost expense trial accordance with development plan provided that style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp global trial party agree conduct global trial then party applicable relevant neurocrine collaborator shall discus good faith determine term under which party will conduct such global trial including allocation between party cost expense decision making process authority trial design protocol management budget overage allocation development activity responsibility data sharing procedure neurocrine shall determine sole discretion whether what extent participates cost sharing other activity related global trial upon agreement party shall enter into written agreement setting forth such agreed term style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp conduct development activity mtpc shall develop compound product field mtpc territory compliance with applicable including fcpa good scientific clinical practice under applicable country which such activity conducted neurocrine shall perform obligation under this agreement compliance with applicable including fcpa good scientific clinical practice under applicable country which such activity conducted style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp record update mtpc shall maintain record sufficient detail good scientific manner appropriate patent regulatory purpose which shall fully properly reflect work done result achieved behalf mtpc performance development activity pursuant this agreement mtpc shall keep regularly style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify informed status development activity with respect compound product field mtpc territory conducted pursuant this agreement without limiting foregoing least mtpc shall provide with summary reasonable detail data result generated obtained course mtpc affiliate sublicensees performance activity with respect compound product field mtpc territory neurocrine shall maintain record sufficient detail good scientific manner appropriate patent regulatory purpose which shall fully properly reflect work done result achieved behalf neurocrine performance development activity requested mtpc pursuant this agreement neurocrine shall keep regularly informed status development activity with respect compound product outside mtpc territory conducted pursuant this agreement without limiting foregoing least neurocrine shall provide with summary reasonable detail data result nbsp generated obtained course neurocrine affiliate collaborator performance development activity requested mtpc pursuant this agreement with respect compound product outside mtpc territory style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp development diligence mtpc shall commercially reasonable effort develop file maas applicable seek pricing reimbursement approval seek maintain regulatory approval product field throughout mtpc territory mtpc shall conduct such activity accordance with development plan style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subcontractor mtpc perform development activity under this agreement through more subcontractor provided that nbsp mtpc will remain responsible work allocated payment such subcontractor same extent would done such work itself nbsp each subcontractor undertakes writing obligation confidentiality regarding confidential information that substantially same those undertaken party pursuant article nbsp each subcontractor agrees writing assign intellectual property developed course performing such work clarity intellectual property owned developed licensed behalf such subcontractor prior independent subcontractor performance such work shall subcontractor property shall assign mtpc mtpc also subcontract work term other than those forth this section nbsp with prior approval style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp material transfer order facilitate development activity contemplated this agreement either party provide other party certain biological material chemical compound controlled supplying party collectively material other party furtherance such development activity except otherwise provided under this agreement such material delivered other party will remain sole property supplying party will used only furtherance development activity conducted accordance with this agreement will used delivered benefit third party except subcontractor without prior written consent supplying party will used compliance with applicable material supplied under this agreement must used with prudence appropriate caution experimental work because their characteristic known except expressly forth this agreement material provided without representation warranty express implied including without style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify limitation implied warranty merchantability fitness particular purpose warranty that material will infringe violate patent other proprietary right third party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small egulatory small small ctivities small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp conduct regulatory activity mtpc shall solely responsible formulating regulatory strategy preparing filing obtaining maintaining regulatory approval product field mtpc territory mtpc affiliate sublicensee shall holder regulatory approval product field mtpc territory shall have responsibility interaction with regulatory authority with respect product field mtpc territory mtpc shall consult with neurocrine through regarding keep neurocrine regularly informed preparation regulatory authority review approval submission communication with regulatory authority with respect product field mtpc territory addition mtpc shall promptly provide neurocrine with copy material document information correspondence received from regulatory authority with english summary thereof upon reasonable request neurocrine with copy other document report communication from regulatory authority relating compound product activity under this agreement with english summary thereof except agreed otherwise party under section nbsp mtpc shall bear expense incurs conduct regulatory activity mtpc territory under this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neurocrine activity neurocrine agrees keep mtpc informed preparation regulatory authority review approval submission communication with regulatory authority with respect product field outside mtpc territory addition neurocrine shall upon reasonable request mtpc promptly provide mtpc with copy material document information correspondence received from regulatory authority outside mtpc territory neurocrine possession neurocrine legal right transfer event that neurocrine data shall incorporated regulatory filing obtain regulatory approval mtpc territory neurocrine shall promptly provide mtpc copy modification correction revision such neurocrine data fulfill mtpc obligation development regulatory approval mtpc territory addition such case neurocrine shall retain record relating supporting such neurocrine data incorporated regulatory filing mtpc territory long regulatory agency mtpc territory requires mtpc affiliate sublicensees keep such record upon mtpc reasonable request neurocrine shall assist mtpc fulfill requirement regulatory agency mtpc territory related neurocrine data incorporated regulatory filing mtpc territory mtpc shall reimburse reasonable internal fully burdened rate external cost incurred neurocrine conduct such activity provided that item cost such activity shall discussed agreed upon advance between party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp inspection audit style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp regulatory authority event mtpc receives correspondence inquiry request inspection audit from regulatory authority which relates neurocrine data mtpc shall promptly notify neurocrine such correspondence inquiry request inspection audit neurocrine shall cooperate with mtpc responding such correspondence inquiry inspection audit concerning neurocrine data mtpc shall reimburse reasonable internal fully burdened rate external cost incurred neurocrine conduct such activity style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp mtpc event that neurocrine data shall incorporated regulatory filing obtain regulatory approval mtpc territory neurocrine shall permit mtpc authorized representative conduct reasonable examination quality inspection such neurocrine data style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp adverse event reporting pharmacovigilance agreement between party nbsp neurocrine shall responsible timely reporting quality complaint safety data relating compound product appropriate regulatory authority outside mtpc territory nbsp except otherwise agreed writing party mtpc shall responsible timely reporting quality complaint safety data relating compound product relevant regulatory authority mtpc territory each case accordance with applicable relevant country regulatory authority party shall cooperate with each other with respect their respective pharmacovigilance responsibility each party shall solely responsible cost relating respective pharmacovigilance responsibility unless agreed otherwise party writing party shall negotiate good faith enter into timely manner mutually acceptable pharmacovigilance agreement with respect compound product unless otherwise mutually agreed such pharmacovigilance agreement shall cover exchange safety information appropriate management pharmacovigilance activity fulfill legal regulatory requirement both inside outside mtpc territory style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small ommercialization small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercialization mtpc shall have exclusive right commercialize product field mtpc territory during term subject term condition this agreement without limiting foregoing during term mtpc will have exclusive right responsibility following with respect product field mtpc territory nbsp establishing commercialization including marketing strategy tactic commercial strategy nbsp establishing pricing reimbursement nbsp managed care contracting nbsp receiving accepting filling order nbsp distribution customer nbsp controlling invoicing order processing collecting account receivable sale nbsp recording sale book account sale style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercialization plan style font size vertical align mtpc shall prepare preliminary binding commercialization plan marketing promotion pricing product field mtpc territory during after first commercial style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify sale mtpc territory mtpc shall prepare binding plan marketing promotion pricing product field such country during after first commercial sale such country which plan shall reasonable scope detail amended mtpc commercialization plan such country mtpc shall update each commercialization plan yearly basis connection with royalty payment under section nbsp cover subsequent shall promptly provide each such update material amendment each commercialization plan neurocrine through without limiting provision this section nbsp through mtpc shall regularly consult with provide update neurocrine regarding commercial strategy commercialization product field mtpc territory style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp diligence during term mtpc shall commercially reasonable effort market promote otherwise commercialize product field throughout mtpc territory without limiting foregoing mtpc shall commercially reasonable effort achieve first commercial sale product each country mtpc territory within reasonable time style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small anufacture small small small small uppl small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp development supply style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp obligation neurocrine itself through affiliate shall supply mtpc affiliate sublicensees requirement compound product including matched placebo form drug product drug product form bulk compound mtpc request development compound product field mtpc territory pursuant separate supply agreement entered into between party development supply agreement along with quality agreement reasonably advance anticipated first development supply drug product mtpc territory unless agreed otherwise party mtpc shall drug product supplied neurocrine under this section nbsp solely conduct development field mtpc territory accordance with term this agreement notwithstanding anything this agreement contrary time mtpc elect manufacture compound product itself development mtpc territory provided that mtpc shall remain responsible payment supply drug product under outstanding purchase order submitted neurocrine style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp price drug product supplied neurocrine development will supplied price nbsp nbsp nbsp price corresponding above nbsp nbsp case drug product strength other than neurocrine will invoice mtpc within after acceptance each shipment drug product notified mtpc pursuant section nbsp mtpc will each such invoice within after receipt thereof price such drug product changed unexpected cost increase such substantial increase material cost such case style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify neurocrine shall notify mtpc proposed changed price reason such change party shall agree good faith supplied updated neurocrine cost good style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp forecasting ordering soon practicable after effective date mtpc shall provide neurocrine with forecast mtpc purchase order drug product development which placed initial after effective date thereafter mtpc will provide neurocrine with binding forecast mtpc subsequent purchase order drug product development prior estimated date placing each such purchase order upon receipt mtpc binding forecast above neurocrine shall confirm whether stock which allocated anticipated mtpc purchase order shall provide forecast stock mtpc following then notify such availability availability forecast such stock mtpc purchase order development shall placed allow than case drug product case lead time prior delivery date specified such purchase order neurocrine will commercially reasonable effort comply with requested delivery date event there available manufacture drug product purchase order drug product development shall placed allow than lead time prior delivery date purchase order purchase order drug product development will cancelable when formed shall coordinate forecasting ordering supply drug product under this section style font size vertical align style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp compliance neurocrine itself through affiliate shall manufacture drug product compliance with applicable accordance with such appropriate quality specification test method formula manufacturing process specified mutual written agreement neurocrine mtpc which changed neurocrine without prior written consent mtpc except required regulatory authority mtpc shall drug product that mtpc knowledge meet then prevailing quality specification test method formula manufacturing process style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp acceptance mtpc shall confirm quality drug product delivered neurocrine cmos conforms specification shall testing method specified mutual agreement neurocrine mtpc case that quantity drug product supplied neurocrine cmos hereunder time delivery conform then prevailing specification neurocrine shall cost replace such quantity drug product with material quality specified such specification mtpc shall neurocrine option expense return neurocrine dispose such quantity drug product that failed meet such specification provided however that mtpc shall have notified neurocrine within from receipt applicable drug product failure such quantity meet specification event before mtpc such drug product purpose mtpc notifies neurocrine within such that drug product conform specification neurocrine have relevant drug product tested appropriate independent laboratory reasonably acceptable mtpc determine finally whether drug product conforms specification result such test style margin margin bottom font size font family time roman align right style font size vertical align confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify carried laboratory shall binding upon party expense laboratory will borne party against which laboratory rule other express implied warranty including warranty merchantability fitness particular purpose specifically disclaimed neurocrine excluded from term sale drug product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp responsibility quality neurocrine shall perform have sole responsibility quality test drug product manufactured neurocrine neurocrine neurocrine shall prepare maintain retain required document data retained sample including batch record certificate analysis statement statement relating manufacturing drug product accordance with applicable regulation shall upon request mtpc furnish mtpc with copy those document data avoidance doubt mtpc perform sole discretion such quality test drug product manufactured neurocrine neurocrine upon receipt according test method transferred neurocrine style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercial supply style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp supply agreement unless until elected otherwise mtpc neurocrine itself through affiliate shall manufacture supply mtpc affiliate sublicensees requirement compound product either nbsp nbsp drug product commercial mtpc territory pursuant separate supply agreement entered into between party supply agreement along with quality agreement reasonably advance anticipated first commercial sale product mtpc territory pursuant supply agreement neurocrine will supply either drug product transfer price nbsp nbsp nbsp price corresponding above nbsp nbsp case drug product strength other than capsule transfer price changed unexpected cost increase such substantial increase material other cost such case neurocrine shall notify mtpc proposed changed transfer price reason such change party shall agree with revision transfer price good faith then party shall negotiate good faith agree with revision transfer price mtpc shall solely responsible formulating supplied behalf neurocrine supplied into drug product packaging labeling such drug product manufactured mtpc drug product supplied behalf neurocrine case commercial field mtpc territory style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp mtpc manufacture transition notwithstanding section nbsp time mtpc assume responsibility manufacturing supplying drug product commercial mtpc territory provided that mtpc shall notify neurocrine least prior anticipated establishment such supply keep neurocrine reasonably informed progress establishing such supply upon such notice neurocrine mtpc will good faith prepare agree schedule plan pursuant which mtpc directly through affiliate cmos will assume such manufacturing responsibility style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify clarity case mtpc assumes manufacturing supplying drug product neurocrine shall unreasonably refuse mtpc right including manufacturing starting material that same neurocrine used manufacture drug product party agree discus good faith joint purchasing arrangement extent permitted applicable style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp formulation activity mtpc desire different formulation drug product connection with development commercialization compound product field mtpc territory from that neurocrine developing using effective date mtpc shall solely responsible related formulation process development activity event will neurocrine obligated supply drug product under this agreement supply agreement different formulation from that neurocrine developing using effective date provided that neurocrine shall provide mtpc with reasonable support assistance mtpc reasonable request provided advance notice provided neurocrine mtpc shall reimburse reasonable internal fully burdened rate external cost incurred neurocrine conduct such activity provided that item cost such activity shall discussed agreed upon advance between party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp technical transfer upon reasonable request from mtpc neurocrine shall forthwith cooperate with mtpc designated manufacturer provide mtpc designated manufacturer with technical assistance with respect neurocrine technology order enable mtpc such neurocrine technology manufacture produce drug product neurocrine shall commercially reasonable effort complete such technical transfer within after such request upon reasonable request from mtpc neurocrine shall forthwith cooperate with mtpc designated analytical testing facility provide mtpc designated analytical testing facility with technical assistance with respect neurocrine technology order enable mtpc such neurocrine technology analyze drug product neurocrine shall commercially reasonable effort complete such technical transfer within after such request mtpc shall reimburse reasonable internal fully burdened rate external cost incurred neurocrine conduct such activity under this section nbsp provided that item cost such activity shall discussed agreed upon advance between party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp information manufacture extent neurocrine itself through affiliate supply drug product development commercialization under this agreement neurocrine shall make available mtpc information possession neurocrine legal right transfer related manufacture drug product enable mtpc maintain obtain regulatory approval mtpc territory neurocrine shall commercially reasonable effort require that allow neurocrine provide mtpc access right manufacturing information possession extent that such information reasonably useful development commercialization compound product field mtpc territory including preparation filing maas product with applicable regulatory authority mtpc territory accordance with this agreement mtpc shall reimburse reasonable internal fully burdened rate external cost incurred neurocrine conduct such style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify activity under this section nbsp provided that item cost such activity shall discussed agreed upon advance between party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small small small small small ayments small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp upfront payment mtpc shall make time payment neurocrine thirty million dollar within thirty nbsp after effective date such amount shall subject twenty percent nbsp withholding mtpc mtpc withhold make payment neurocrine unless prior such thirty nbsp period mtpc received from neurocrine document necessary useful avoiding withholding withholding avoidance document mtpc withholds then mtpc will reasonably assist neurocrine obtaining refund withheld amount from applicable japanese authority upon receipt from neurocrine withholding avoidance document subsequent date example withholding avoidance document between japan united state form application form income convention form application enjoying income benefit form issued department treasury notwithstanding foregoing event that neurocrine will fail provide withholding avoidance document prior such thirty nbsp period party agree extend date upfront payment until neurocrine will provide such withholding avoidance document mtpc style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp milestone payment style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp regulatory commercialization milestone payment style margin margin bottom text indent font size font family time roman align justify neurocrine shall notify mtpc first achievement each milestone event below whether neurocrine affiliate neurocrine collaborator within thirty nbsp after each such notice mtpc shall neurocrine refundable creditable milestone payment corresponding such milestone event shown below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign align center style border solid padding left bgcolor style margin left text indent font size font family time roman align center regulatory commercialization milestone event valign bottom bgcolor style border solid border bottom solid valign align center style border solid border right solid border bottom solid bgcolor milestone payment nbsp nbsp dollar style font family time roman font size valign style border left solid border right solid border bottom solid padding left style margin left text indent font size font family time roman nbsp nbsp valign bottom style border bottom solid valign bottom align center style border right solid border bottom solid style font family time roman font size valign style border left solid border right solid padding left style margin left text indent font size font family time roman nbsp nbsp valign bottom valign bottom align center style border right solid style font size height style border left solid border right solid padding left nbsp height colspan style border right solid nbsp style font family time roman font size valign style border left solid border right solid padding left style margin left text indent font size font family time roman nbsp nbsp valign bottom valign bottom align center style border right solid style font size height style border left solid border right solid padding left nbsp height colspan style border right solid nbsp style font family time roman font size valign style border left solid border right solid padding left style margin left text indent font size font family time roman nbsp nbsp valign bottom valign bottom style border right solid nbsp style font size height style border left solid border right solid padding left nbsp height colspan style border right solid nbsp style font family time roman font size valign style border left solid border right solid border bottom solid padding left nbsp valign bottom style border bottom solid valign bottom style border right solid border bottom solid nbsp table style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign style border left solid border solid border right solid padding left style margin margin bottom margin left text indent font size font family time roman nbsp nbsp style font size vertical align valign bottom style border solid valign bottom style border solid border right solid nbsp style font family time roman font size valign style border left solid border right solid padding left nbsp valign bottom valign bottom align center style border right solid nbsp nbsp nbsp style font size height style border left solid border right solid padding left nbsp height colspan style border right solid nbsp style font family time roman font size valign style border left solid border right solid padding left nbsp valign bottom valign bottom align center style border right solid style font size height style border left solid border right solid padding left nbsp height colspan style border right solid nbsp style font family time roman font size valign style border left solid border right solid border bottom solid padding left nbsp valign bottom style border bottom solid valign bottom style border right solid border bottom solid align center nbsp nbsp nbsp style font size margin margin bottom align left nbsp table style margin margin bottom text indent font size font family time roman align justify within thirty nbsp after first achievement each milestone event below whether mtpc affiliate sublicensees mtpc shall neurocrine refundable creditable milestone payment corresponding such milestone event shown below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign align center style border solid padding left bgcolor style margin left text indent font size font family time roman align center regulatory commercialization milestone event valign bottom bgcolor style border solid border bottom solid valign align center style border solid border right solid border bottom solid bgcolor milestone payment nbsp nbsp dollar style font family time roman font size valign style border left solid border right solid padding left style margin left text indent font size font family time roman valign bottom valign bottom style border right solid align center style font size margin margin bottom align left nbsp style font size height style border left solid border solid border right solid padding left nbsp height colspan style border solid border right solid nbsp style font family time roman font size valign style border left solid border right solid padding left style margin left text indent font size font family time roman valign bottom valign bottom style border right solid align center style font size margin margin bottom align left nbsp style font size height style border left solid border solid border right solid padding left nbsp height colspan style border solid border right solid nbsp style font family time roman font size valign style border left solid border right solid padding left style margin left text indent font size font family time roman valign bottom valign bottom style border right solid align center style font size margin margin bottom align left nbsp style font size height style border left solid border solid border right solid padding left nbsp height colspan style border solid border right solid nbsp style font family time roman font size valign style border left solid border right solid border bottom solid padding left style margin margin bottom margin left text indent font size font family time roman style font size margin margin bottom nbsp valign bottom style border bottom solid valign bottom style border right solid border bottom solid align center style font size margin margin bottom align left nbsp table style margin margin bottom font size font family time roman align justify notwithstanding foregoing case daily drug price product determined regulatory authority lower than then milestone payment credit against royalty payable neurocrine pursuant section nbsp style margin margin bottom text indent font size font family time roman align justify clarity milestone payment forth this section nbsp shall payable only once upon first achievement applicable milestone event compound product maximum total amount payable under this section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp annual sale milestone style margin margin bottom text indent font size font family time roman align justify within thirty nbsp after each calendar quarter which aggregate annual sale product field mtpc territory first reach threshold indicated milestone event listed below mtpc shall neurocrine corresponding refundable creditable milestone payment forth below style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width bgcolor style font family time roman font size valign nowrap align center style border left solid border solid border bottom solid padding left annual sale milestone event valign bottom style border left solid border solid border bottom solid valign bottom align center style border solid border right solid border bottom solid padding right milestone nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp payment nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font family time roman font size valign style border left solid padding left style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman nbsp nbsp nbsp nbsp style font size margin margin bottom nbsp valign bottom style border left solid border bottom solid valign bottom style border right solid border bottom solid style font size margin margin bottom nbsp style margin bottom margin font size font family time roman align center nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size margin margin bottom align left nbsp style font family time roman font size valign style border solid padding left style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman nbsp nbsp nbsp nbsp style font size margin margin bottom nbsp valign bottom style border bottom solid valign bottom style border right solid border bottom solid align center nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size margin margin bottom align left nbsp style font family time roman font size valign style border left solid border right solid border bottom solid padding left style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman nbsp nbsp nbsp nbsp style font size margin margin bottom nbsp valign bottom style border bottom solid valign bottom style border right solid border bottom solid align center nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size margin margin bottom align left nbsp table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp clarity annual sale milestone payment forth this section nbsp shall payable only once upon first achievement applicable milestone event shall additive that three nbsp milestone event forth section nbsp achieved same calendar year mtpc shall neurocrine three nbsp milestone payment maximum total amount payable under this section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp royalty payment style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp royalty rate subject term condition this agreement mtpc shall neurocrine royalty forth below aggregate annual sale product each country mtpc territory during royalty term calculated multiplying applicable royalty rate forth below corresponding amount aggregate sale product such country such calendar year style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width bgcolor style font family time roman font size valign nowrap align center style border left solid border solid border bottom solid padding left aggregate annual sale product mtpc territory tier valign bottom style border left solid border solid border bottom solid valign bottom colspan align center style border solid border bottom solid royalty rate nbsp nbsp nbsp nbsp valign bottom style border solid border right solid border bottom solid padding right nbsp style font family time roman font size valign style border left solid padding left style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman annual sale style font size margin margin bottom nbsp valign bottom style border left solid border bottom solid valign bottom style border bottom solid style font size margin margin bottom nbsp style margin bottom margin font size font family time roman nbsp style font size margin margin bottom nbsp valign bottom style border bottom solid style font size margin margin bottom nbsp style margin bottom margin font size font family time roman align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size margin margin bottom align left nbsp nowrap valign bottom style border right solid border bottom solid padding right style font size margin margin bottom nbsp style margin bottom margin font size font family time roman nbsp nbsp style font size margin margin bottom nbsp style font family time roman font size valign style border solid padding left style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman portion annual sale excess style font size margin margin bottom nbsp valign bottom style border bottom solid valign bottom style border bottom solid nbsp style font size margin margin bottom nbsp valign bottom style border bottom solid align center nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size margin margin bottom align left nbsp nowrap valign bottom style border right solid border bottom solid padding right nbsp nbsp style font size margin margin bottom nbsp style font family time roman font size valign style border left solid border right solid border bottom solid padding left style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman portion annual sale excess style font size margin margin bottom nbsp valign bottom style border bottom solid valign bottom style border bottom solid nbsp style font size margin margin bottom nbsp valign bottom style border bottom solid align center nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size margin margin bottom align left nbsp nowrap valign bottom style border right solid border bottom solid padding right nbsp nbsp style font size margin margin bottom nbsp table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp royalty term royalty shall paid product product country country basis mtpc territory from first commercial sale such product such country until latest nbsp expiration font style white space nowrap font style white space nowrap last expire font font valid claim neurocrine patent joint patent covering composition method manufacture method field such product such country after first commercial sale such product such country royalty term notwithstanding other provision this agreement nbsp royalty rate provided section nbsp such product shall reduced such country during royalty term after expiration font style white space nowrap font style white space nowrap last expire font font valid claim neurocrine patent only valid claim still existing valid claim style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify joint patent valid claim containing only joint compound improvement invention until expiration font style white space nowrap font style white space nowrap last expire font font valid claim joint patent expiration font style white space nowrap font style white space nowrap last expire font font valid claim containing only joint compound improvement invention nbsp royalty shall paid valid claim neurocrine patent such valid claim contains only mtpc compound improvement invention style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp generic competition more generic product product launched country mtpc territory during royalty term such product such country royalty rate provided section nbsp such product shall reduced such country calendar quarter which applicable decline occurs future calendar quarter unless until such generic product longer sold increase above threshold value described above style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp deduction third party settlement mtpc shall responsible payment owed third party connection with settlement enters under section nbsp product product country country basis mtpc deduct royalty payment actually paid such third party under such settlement agreement from royalty payment owed neurocrine under this section nbsp provided that event shall deduction under this section nbsp section nbsp reduce royalty calendar quarter with respect such product such country than amount that would otherwise neurocrine style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small ayment small small ecords small small udits small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp payment report nbsp nbsp nbsp nbsp royalty payment mtpc neurocrine under section nbsp shall calculated reported each calendar quarter final report each calendar quarter setting forth country country basis sale product mtpc affiliate sublicensees mtpc territory sufficient detail permit confirmation accuracy royalty payment made including each country number product sold gross sale sale product including deduction from gross sale arrive sale royalty payable method used calculate royalty exchange rate used adjustment royalty accordance with section nbsp shall provided neurocrine within after each calendar quarter royalty payment under section nbsp shall paid from mtpc japan office within after each calendar quarter style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exchange rate manner place payment nbsp nbsp nbsp nbsp reference dollar herein shall refer dollar reference herein shall refer japanese payment hereunder shall payable dollar when conversion payment from currency other than dollar required such conversion shall exchange rate equal average daily rate exchange currency country from which such payment payable dollar published wall street journal western edition during calendar quarter which applicable sale were style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify made payment owed under this agreement shall made wire transfer immediately available fund bank account designated writing neurocrine unless otherwise specified writing neurocrine style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp cooperation coordination party acknowledge agree that their mutual objective intent minimize extent feasible compliance with applicable payable with respect their collaborative effort under this agreement that they shall reasonable effort cooperate coordinate with each other achieve such objective such mtpc shall change country from which payment neurocrine originate without prior written consent neurocrine style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp payment neurocrine will levied account payment made under this agreement required withheld mtpc from payment made neurocrine under this agreement neurocrine will provide withholding avoidance document mtpc prior such payment neurocrine avoiding withholding case withholding avoidance document available mtpc date such payment neurocrine mtpc will nbsp deduct such from payment made neurocrine nbsp timely proper taxing authority nbsp send proof payment neurocrine certify receipt taxing authority within following such payment purpose this section nbsp each party agrees provide other with reasonably requested assistance enable deduction mtpc appropriate recovery neurocrine which assistance includes provision form other information that reasonably necessary order mtpc withhold withhold reduced rate under applicable bilateral treaty same amended from time time notwithstanding foregoing case withholding avoidance document available mtpc date such payment neurocrine party agree extend date upfront payment until neurocrine will provide such withholding avoidance document mtpc style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp record audit mtpc shall keep shall cause affiliate sublicensees keep complete accurate record pertaining sale other disposition product sufficient detail permit neurocrine confirm accuracy royalty payment hereunder such record shall kept such period time required applicable than following calendar quarter which they pertain neurocrine shall have right cause independent international certified public accounting firm reasonably acceptable mtpc audit such record confirm sale royalty other payment period covering more than following calendar quarter which they pertain such audit exercised during normal business hour upon reasonable prior written notice mtpc prompt adjustment shall made party reflect result such audit neurocrine shall bear full cost such audit unless such audit discloses underpayment mtpc more than amount royalty other payment under this agreement applicable calendar quarter which case mtpc shall bear cost such audit shall promptly remit neurocrine amount underpayment overpayment mtpc revealed audit shall credited style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify against future payment owed mtpc neurocrine further payment shall refunded neurocrine request mtpc style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp late payment event that payment under this agreement paid when accordance with applicable provision this agreement payment shall accrue interest from date rate month provided however that event shall such rate exceed maximum legal annual interest rate payment such interest shall limit party entitled receive payment from exercising other right have consequence lateness payment style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small ntellectual small small roperty small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ownership style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp data data generated connection with development regulatory manufacturing commercial activity with respect compound product conducted behalf mtpc affiliate sublicensees mtpc data shall sole exclusive property mtpc affiliate sublicensees applicable provided however mtpc assigns shall assign data related mtpc compound improvement invention joint compound improvement invention neurocrine upon neurocrine request data generated connection with development regulatory manufacturing commercial activity with respect compound product conducted behalf neurocrine affiliate neurocrine collaborator neurocrine data shall sole exclusive property neurocrine affiliate neurocrine collaborator applicable style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp invention inventorship invention will determined accordance with standard inventorship conception under patent party will work together resolve issue regarding inventorship ownership invention ownership invention will allocated follows style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neurocrine will solely invention patent claiming such invention that relate composition manufacture compound improvement such composition manufacture each compound invention including joint compound improvement invention mtpc compound improvement invention compound invention will included neurocrine know patent claiming such compound invention joint compound improvement invention mtpc compound improvement invention will included neurocrine patent mtpc assigns shall assign right joint compound improvement invention mtpc compound improvement invention neurocrine right patent claiming joint compound improvement invention mtpc compound improvement invention style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp invention discovered made conceived conceived reduced practice solely nbsp more employee contractor neurocrine affiliate patent claiming such invention after effective date during term this agreement shall solely owned neurocrine invention other than compound invention joint compound improvement invention mtpc compound improvement invention discovered made conceived conceived reduced practice solely style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify more employee contractor mtpc affiliate patent claiming such invention after effective date during term this agreement shall solely owned mtpc style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint invention joint patent which clarity exclude compound invention joint compound improvement invention mtpc compound improvement invention patent claiming compound invention joint compound improvement invention mtpc compound improvement invention shall jointly owned neurocrine mtpc subject right license granted under this agreement each party shall have right grant license joint invention joint patent territory mtpc mtpc territory neurocrine outside mtpc territory without other party consent without duty account other party such license provided however that each party shall notify other party writing such license granted third party each party hereby waif right have under country require such consent accounting style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp patent prosecution maintenance style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neurocrine patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject this section nbsp neurocrine shall have sole right obligation control preparation filing prosecution including interference reissue proceeding examination maintenance neurocrine patent counsel choice neurocrine shall keep mtpc reasonably informed progress with regard preparation filing prosecution maintenance neurocrine patent including content timing jurisdiction filing such neurocrine patent shall consult with consider good faith request suggestion mtpc with respect strategy filing prosecuting neurocrine patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp event that neurocrine desire abandon cease prosecution maintenance neurocrine patent neurocrine shall provide reasonable prior written notice mtpc such intention abandon which notice shall extent possible given later than prior next deadline action that must taken with respect such neurocrine patent relevant patent office such case upon mtpc written election provided later than after such notice from neurocrine mtpc shall have right assume prosecution maintenance such neurocrine patent mtpc expense such case mtpc shall keep neurocrine reasonably informed progress with regard preparation filing prosecution maintenance neurocrine patent including content timing jurisdiction filing such neurocrine patent mtpc provide such election within after such notice from neurocrine neurocrine sole discretion continue prosecution maintenance such neurocrine patent discontinue prosecution maintenance such neurocrine patent style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp mtpc patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject this section nbsp mtpc shall have sole right obligation control preparation filing prosecution including interference reissue proceeding examination maintenance mtpc patent worldwide sole cost expense counsel choice mtpc shall keep neurocrine reasonably informed status filing prosecution maintenance mtpc patent shall consult with consider good faith request suggestion neurocrine with respect strategy filing prosecuting mtpc patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp event that mtpc desire abandon cease prosecution maintenance mtpc patent mtpc shall provide reasonable prior written notice neurocrine such intention abandon which notice shall extent possible given later than prior next deadline action that must taken with respect such mtpc patent relevant patent office such case upon neurocrine written election provided later than after such notice from mtpc neurocrine shall have right assume prosecution maintenance such mtpc patent neurocrine expense neurocrine provide such election within after such notice from mtpc mtpc sole discretion continue prosecution maintenance such mtpc patent discontinue prosecution maintenance such mtpc patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neurocrine shall have first right obligation prepare file prosecute including interference reissue proceeding examination maintain joint patent using patent counsel selected neurocrine reasonably acceptable mtpc mtpc shall reimburse neurocrine external patent cost incurred with respect preparation filing prosecution maintenance joint patent mtpc territory within from date invoice such cost expense provided neurocrine event that mtpc reimburse neurocrine such external patent cost joint patent mtpc notifies neurocrine writing that elect cease reimbursing neurocrine such external patent cost joint patent mtpc territory mtpc shall execute such document perform such mtpc expense reasonably necessary effect assignment mtpc entire right title interest such joint patent neurocrine such patent shall cease either joint patent neurocrine patent shall longer subject license other right granted neurocrine mtpc under this agreement neurocrine shall agree furnish mtpc with copy document relevant such preparation filing prosecution maintenance with respect such joint patent sufficient time allow review mtpc incorporate good faith comment mtpc prior taking action implement such decision otherwise keep mtpc reasonably informed status preparation filing prosecution maintenance such joint patent mtpc territory style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp event that neurocrine desire abandon cease prosecution maintenance joint patent mtpc territory except event party style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify mutually decide abandon cease prosecution maintenance enforcement such joint patent neurocrine shall provide reasonable prior written notice mtpc such intention abandon which notice shall extent possible given later than prior next deadline action that must taken with respect such joint patent relevant patent office such case mtpc elect continue prosecution maintenance such joint patent mtpc territory sole discretion expense which case right such joint patent mtpc territory shall assigned mtpc neurocrine shall execute such document perform such expense reasonably necessary effect assignment entire right title interest such joint patent mtpc territory mtpc such assignment shall completed timely manner allow mtpc continue prosecution maintenance such joint patent such joint patent assigned shall longer subject license other right granted neurocrine mtpc under this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp cooperation party each party agrees cooperate fully preparation filing prosecution maintenance patent under section nbsp obtaining maintenance patent term extension supplementary protection certificate their equivalent with respect thereto respectively cost except expressly forth otherwise this article such cooperation includes nbsp executing paper instrument requiring employee contractor execute such paper instrument enable other party apply prosecute patent application country permitted section nbsp nbsp promptly informing other party matter coming such party attention that affect preparation filing prosecution maintenance such patent application style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp infringement third party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notice event that either neurocrine mtpc becomes aware infringement threatened infringement third party neurocrine patent mtpc patent joint patent declaratory judgment equivalent action challenging neurocrine patent mtpc patent joint patent connection with such infringement will notify other party writing that effect such notice shall include evidence support allegation infringement threatened infringement declaratory judgment equivalent action filed such third party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neurocrine patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject this section nbsp neurocrine shall have first right between neurocrine mtpc obligation bring control action proceeding with respect infringement challenge neurocrine patent expense counsel choice mtpc shall have right expense represented such action mtpc territory counsel choice neurocrine counsel will reasonably cooperate with mtpc counsel strategizing preparing prosecuting such action proceeding mtpc territory neurocrine fails bring action proceeding with respect infringement neurocrine patent mtpc territory within nbsp following style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify notice alleged infringement declaratory judgment nbsp before time limit forth appropriate regulation filing such action whichever come first mtpc shall have right obligation bring control such action mtpc territory expense counsel choice neurocrine shall have right expense represented such action counsel choice style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp except otherwise agreed party part cost sharing arrangement recovery damage realized result such action proceeding with respect neurocrine patent shall used first reimburse party documented pocket legal expense relating action proceeding rata basis remaining compensatory damage relating product including lost sale lost profit with respect product shall retained party that brought controlled such action proceeding case that mtpc brought controlled such action proceeding such remaining compensatory damage shall deemed sale subject royalty payment neurocrine accordance with royalty provision section punitive damage shall equally shared party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp mtpc patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp mtpc shall have sole right between neurocrine mtpc obligation bring control action proceeding with respect infringement challenge mtpc patent mtpc territory expense counsel choice subject this section nbsp recovery damage realized result such action proceeding mtpc with respect mtpc patent mtpc territory shall used first reimburse mtpc documented pocket legal expense relating action proceeding remaining compensatory punitive other damage relating product including lost sale lost profit with respect product shall deemed sale under section nbsp this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject this section nbsp neurocrine shall have first right between neurocrine mtpc obligation bring control action proceeding with respect infringement challenge mtpc patent outside mtpc territory expense counsel choice mtpc shall have right expense represented such action counsel choice neurocrine counsel will reasonably cooperate with mtpc counsel strategizing preparing prosecuting such action proceeding neurocrine fails bring action proceeding with respect infringement challenge mtpc patent outside mtpc territory within nbsp following notice alleged infringement nbsp before time limit forth appropriate regulation filing such action whichever come first mtpc shall have right bring control such action expense counsel choice neurocrine shall have right expense represented such action counsel choice except otherwise agreed party part cost sharing arrangement recovery damage realized result such action proceeding with respect mtpc patent outside mtpc territory shall used first reimburse party documented pocket legal expense relating action proceeding rata basis remaining compensatory style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify damage relating product including lost sale lost profit with respect product shall retained party that brought controlled such action proceeding punitive damage shall equally shared party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject this section nbsp mtpc shall have first right between mtpc neurocrine obligation bring control action proceeding with respect infringement challenge joint patent mtpc territory expense counsel choice neurocrine shall have right expense represented such action counsel choice mtpc fails bring action proceeding with respect infringement challenge joint patent within nbsp following notice alleged infringement before time limit forth appropriate regulation filing such action whichever come first neurocrine shall have right obligation bring control such action expense counsel choice mtpc shall have right expense represented such action counsel choice except otherwise agreed party part cost sharing arrangement recovery damage realized result such action proceeding with respect joint patent mtpc territory shall used first reimburse party documented pocket legal expense relating action proceeding rata basis remaining compensatory damage relating product including lost sale lost profit with respect product shall retained party that brought controlled such action proceeding case that mtpc brought controlled such action proceeding such remaining compensatory damage shall deemed sale subject royalty payment neurocrine accordance with royalty provision section punitive damage shall equally shared party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject this section nbsp neurocrine shall have first right between neurocrine mtpc obligation bring control action proceeding with respect infringement challenge joint patent outside mtpc territory expense counsel choice mtpc shall have right expense represented such action counsel choice neurocrine fails bring action proceeding with respect infringement challenge joint patent within nbsp following notice alleged infringement nbsp before time limit forth appropriate regulation filing such action whichever come first mtpc shall have right obligation bring control such action expense counsel choice neurocrine shall have right expense represented such action counsel choice except otherwise agreed party part cost sharing arrangement recovery damage realized result such action proceeding with respect joint patent outside mtpc territory shall used first reimburse party documented pocket legal expense relating action proceeding rata basis remaining compensatory damage relating product including lost sale lost profit with respect product shall retained party that brought controlled such action proceeding punitive damage shall equally shared party style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp cooperation event party brings action accordance with this section nbsp other party shall cooperate fully including required bring such action furnishing power attorney being named party such action style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp infringement third party right each party shall promptly notify other writing allegation third party that manufacture development importation marketing sale compound product mtpc territory infringes infringe intellectual property right third party each infringement claim notice shall forth fact infringement claim reasonable detail mtpc shall have first right control defense such claim expense counsel choice neurocrine shall have right expense represented such action counsel choice mtpc fails defend against such action notifies neurocrine that intend defend against such action within nbsp following notice alleged infringement nbsp before time limit forth appropriate regulation response such action whichever come first neurocrine shall have right obligation defend such action expense counsel choice mtpc shall have right expense represented such action counsel choice mtpc enters into settlement such action with applicable third party such action relates claim that neurocrine technology infringes intellectual property right such third party that provides royalty payment such third party mtpc then mtpc shall have right credit such payment against royalty payable neurocrine extent forth section nbsp notwithstanding foregoing action subject section nbsp will governed section nbsp this section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp consent settlement neither party shall unilaterally enter into settlement compromise action proceeding under this article nbsp that would manner alter diminish derogation other party right under this agreement without prior written consent such other party which shall unreasonably withheld style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp trademark mtpc shall responsible trademark trade name branding logo related product field mtpc territory subject consultation with neurocrine through mtpc shall responsible selecting registering prosecuting defending maintaining such mark mtpc sole discretion cost expense style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neurocrine controlled patent outside mtpc territory clarity neurocrine reserve right prepare file prosecute including interference reissue proceeding examination maintain defend enforce patent owned controlled neurocrine related compound product outside mtpc territory other than joint patent event that neurocrine becomes aware infringement threatened infringement third party neurocrine patent outside mtpc territory declaratory judgment equivalent action challenging neurocrine patent connection with such infringement outside mtpc territory neurocrine shall notify mtpc writing that effect style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small epresentations small small small small arranties small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp mutual representation warranty each party represents warrant other party that effective date nbsp duly organized validly existing under jurisdiction incorporation formation full corporate other power authority enter into this agreement carry provision hereof nbsp duly authorized execute deliver this agreement perform obligation hereunder person person executing this agreement behalf been duly authorized requisite corporate partnership action nbsp this agreement legally binding upon enforceable accordance with term conflict with agreement instrument understanding oral written which party which bound violate material regulation court governmental body administrative other agency having jurisdiction over nbsp right grant license granted under this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp mutual covenant style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp employee consultant contractor nbsp nbsp each party covenant that obtained will obtain written agreement from each employee consultant contractor perform development activity pursuant this agreement which agreement will obligate such person obligation confidentiality assign invention manner consistent with provision this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp debarment nbsp nbsp each party represents warrant covenant other party that debarred disqualified under federal food drug cosmetic amended comparable country jurisdiction other than will during term employ service person debarred disqualified connection with activity relating compound product event that either party becomes aware debarment disqualification threatened debarment disqualification person providing service such party including party itself affiliate neurocrine collaborator sublicensees that directly indirectly relate activity contemplated this agreement such party shall immediately notify other party writing such party shall cease employing contracting with retaining such person perform such service style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp compliance nbsp nbsp each party covenant follows style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp performance obligation under this agreement such party shall comply shall cause affiliate employee contractor comply with applicable rule regulation style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp such party affiliate employee contractor shall connection with performance their respective obligation under this agreement directly indirectly through third party promise offer authorize style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify payment money give promise offer give authorize giving anything value public official entity other person purpose obtaining retaining business with directing business person including without limitation either party each party represents warrant that effective date such party knowledge affiliate employee contractor have directly indirectly promised offered provided corrupt payment gratuity emolument bribe kickback illicit gift hospitality other illegal unethical benefit public official entity other person connection with performance such party obligation under this agreement each party covenant that affiliate employee contractor shall directly indirectly engage foregoing style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp such party affiliate their respective employee contractor connection with performance their respective obligation under this agreement shall cause such other party indemnitees violation fcpa export control other applicable rule regulation otherwise cause reputational harm such other party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp such party shall immediately notify other party such party information suspicion that there violation fcpa export control other applicable rule regulation connection with performance this agreement development manufacture commercialization product style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp connection with performance obligation under this agreement such party shall comply shall cause affiliate employee contractor comply with such party anti corruption anti bribery policy copy which been provided other party prior effective date style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp other party will have right upon reasonable prior written notice during such party regular business hour audit such party book record event that suspected violation representation warranty covenant this section nbsp need investigated style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp event that such party violated been suspected violating representation warranty covenant this section nbsp such party will cause affiliate personnel others working under direction control submit periodic training that such party will provide anti corruption compliance style margin margin bottom text indent font size font family time roman align justify viii nbsp nbsp nbsp nbsp such party will other party request annually certify such other party writing such party compliance connection with performance such party obligation under this agreement with representation warranty covenant section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp each party shall have right suspend terminate this agreement entirety where there credible finding after reasonable investigation that style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify other party connection with performance such other party obligation under this agreement violated fcpa style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp additional neurocrine representation warranty covenant neurocrine represents warrant covenant applicable mtpc that effective date style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp letter agreement list patent mtpc territory effective date that claim composition matter style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neurocrine made available mtpc review information document related neurocrine technology requested mtpc safety data style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neurocrine received written notice from third party that development compound product conducted neurocrine prior effective date infringed patent third party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neurocrine effective date will during term grant right third party under neurocrine technology joint patent that would conflict with right granted mtpc hereunder style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp claim action been brought neurocrine knowledge threatened writing third party alleging that neurocrine patent invalid unenforceable neurocrine patent subject interference opposition cancellation other protest proceeding style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neurocrine knowledge effective date development manufacture importation offer sale sale field mtpc territory infringe issued patent third party patent application issued same form when they were published mtpc territory style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp neurocrine knowledge third party infringing misappropriating infringed misappropriated neurocrine technology mtpc territory style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp additional mtpc representation warranty covenant nbsp nbsp nbsp nbsp mtpc represents warrant covenant neurocrine that effective date mtpc granted will grant during term right third party under mtpc technology that would conflict with right granted neurocrine hereunder mtpc also represents warrant neurocrine that reviewed document data other information provided from neurocrine related neurocrine technology that opportunity request such information requires style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp disclaimer nbsp nbsp nbsp nbsp except expressly forth this agreement technology intellectual property right provided each style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify party hereunder provided each party expressly disclaims warranty kind express implied including warranty design merchantability fitness particular purpose noninfringement intellectual property right third party arising from course dealing usage trade practice case with respect thereto without limiting foregoing nbsp neither party represents warrant that data obtained from conducting clinical trial country jurisdiction will comply with regulation other country jurisdiction nbsp neither party represents warrant success study test conducted pursuant this agreement safety usefulness purpose technology provides hereunder style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small ndemnification small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp indemnification neurocrine neurocrine hereby agrees defend indemnify hold harmless mtpc affiliate sublicensees their respective director officer employee agent each mtpc indemnitee from against liability expense loss including reasonable legal expense attorney collectively loss which mtpc indemnitee become subject result claim demand action other proceeding third party extent such loss arise nbsp development handling storage sale other disposition compound product neurocrine affiliate neurocrine collaborator excluding activity behalf mtpc affiliate sublicensees nbsp negligence willful misconduct neurocrine indemnitee nbsp breach neurocrine warranty representation covenant agreement made neurocrine this agreement except each case extent such loss arise negligence willful misconduct mtpc indemnitee breach mtpc warranty representation covenant agreement made mtpc this agreement supply agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp indemnification mtpc mtpc hereby agrees defend indemnify hold harmless neurocrine affiliate neurocrine collaborator their respective director officer employee agent each neurocrine indemnitee from against loss which neurocrine indemnitee become subject result claim demand action other proceeding third party extent such loss arise nbsp development handling storage sale other disposition compound product mtpc affiliate sublicensees excluding activity behalf neurocrine affiliate neurocrine collaborator nbsp negligence willful misconduct mtpc indemnitee nbsp breach mtpc warranty representation covenant agreement made mtpc this agreement except each case extent such loss arise negligence willful misconduct neurocrine indemnitee breach neurocrine warranty representation covenant agreement made neurocrine this agreement supply agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp procedure nbsp nbsp party that intends claim indemnification under this article nbsp indemnitee shall promptly notify indemnifying party indemnitor writing third party claim demand action other proceeding each claim respect which indemnitee intends claim such indemnification indemnitor shall have sole control defense settlement thereof indemnitee participate expense indemnitor defense settlement negotiation claim with counsel indemnitee selection indemnity arrangement this article nbsp shall apply amount paid settlement action with respect claim such settlement effected without consent indemnitor which consent shall withheld delayed unreasonably failure deliver written notice indemnitor within reasonable time after commencement action with respect third party claim shall only relieve indemnitor indemnification obligation under this article nbsp extent indemnitor actually prejudiced thereby indemnitee shall cooperate fully with indemnitor legal representative investigation action with respect claim covered this indemnification style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp insurance nbsp nbsp each party expense shall maintain product liability other appropriate insurance self insure amount consistent with sound business practice reasonable light obligation under this agreement during term each party shall provide certificate insurance evidence self insurance evidencing such coverage other party upon request style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp limitation liability nbsp nbsp nbsp nbsp except liability breach article unless otherwise expressly stated this agreement neither party shall entitled recover from other party special incidental consequential punitive damage connection with this agreement license granted hereunder provided however that this section nbsp shall construed limit either party indemnification obligation under this article style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small onfidentiality small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp confidential information except extent expressly authorized this agreement otherwise agreed writing party party agree that style font size vertical align receiving party shall keep confidential shall publish otherwise disclose shall purpose other than expressly provided this agreement confidential information other party under this agreement both party shall keep confidential subject section nbsp shall publish otherwise disclose term this agreement each party other party confidential information only extent required accomplish purpose this agreement including exercising right performing obligation each party will least same standard care protect proprietary confidential information than reasonable care ensure that employee agent consultant contractor other representative disclose make unauthorized confidential information other party each party will promptly notify other upon style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify discovery unauthorized disclosure confidential information other party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exception nbsp nbsp obligation confidentiality restriction under section nbsp will apply information that receiving party prove competent written evidence nbsp hereafter becomes through failure part receiving party generally known available public nbsp known receiving party time receiving such information other than previous disclosure disclosing party affiliate employee agent consultant contractor nbsp hereafter furnished receiving party without restriction third party obligation confidentiality limitation with respect thereto matter right nbsp independently discovered developed receiving party without confidential information belonging disclosing party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp authorized disclosure nbsp nbsp each party disclose confidential information belonging other party expressly permitted this agreement extent such disclosure reasonably necessary following instance style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp filing prosecuting maintaining patent permitted this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp regulatory filing product that such party license right develop hereunder given country jurisdiction style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp prosecuting defending litigation permitted this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp complying with applicable court order governmental regulation style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp disclosure affiliate employee consultant contractor agent neurocrine collaborator case neurocrine sublicensees case mtpc each case need know basis connection with development manufacture commercialization compound product accordance with term this agreement supply agreement each case under written obligation confidentiality least stringent those herein style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp disclosure potential actual investor acquirer licensee other financial commercial partner solely purpose evaluating carrying actual potential investment acquisition collaboration each case under written obligation confidentiality least stringent those herein style margin margin bottom font size font family time roman align justify notwithstanding foregoing event party required make disclosure other party confidential information pursuant section nbsp will except where impracticable give reasonable advance notice other party such disclosure effort secure confidential treatment such confidential information least diligent such party would protect confidential information event than style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify reasonable effort event party agree take reasonable action avoid disclosure confidential information hereunder information disclosed pursuant section nbsp nbsp shall remain confidential information subject restriction forth this agreement including foregoing provision this article style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp publication each party shall have right review comment material proposed disclosure publication other party regarding result other information regarding other party development activity with respect product whether oral presentation manuscript abstract reasonable opinion submitting party negatively affect development commercialization product mtpc territory neurocrine publication outside mtpc territory mtpc publication case sake clarity press release other disclosure investment community party shall follow process forth section nbsp below process contained this section nbsp before such material submitted publication presentation such material made each party shall deliver complete copy other party least prior submitting material publisher initiating other disclosure each party shall review such material give comment other party within receipt such material with respect oral presentation material abstract each party shall make reasonable effort expedite review such material abstract shall return such item soon practicable other party with appropriate comment event later than from receipt each party shall comply with other party request delete reference confidential information such material agrees delay submission publication other public disclosure period additional purpose preparing filing appropriate patent application style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp publicity public disclosure party agree issue initial press release substantially form agreed prior effective date issue promptly practicable following effective date understood that each party desire required issue subsequent press release relating this agreement activity hereunder party agree consult with each other reasonably good faith with respect text timing such press release prior issuance thereof extent practicable provided that party unreasonably withhold condition delay consent such release that either party issue such press release make such disclosure other applicable agency determines based advice counsel reasonably necessary comply with regulation appropriate market disclosure each party shall provide other party with advance notice legally required disclosure extent practicable party will consult with each other provision this agreement redacted filing made party with otherwise required applicable provided that each party shall have right make such filing reasonably determines necessary under applicable addition following initial press release announcing this agreement either party shall free disclose without other party prior written consent existence this agreement identity other party those term agreement which have already been publicly disclosed accordance herewith style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp prior confidentiality agreement effective date term this article shall supersede prior disclosure secrecy confidentiality agreement style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify between party their affiliate relating subject this agreement including confidentiality agreement information disclosed pursuant such prior agreement shall deemed confidential information purpose this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp equitable relief given nature confidential information competitive damage that party would suffer upon unauthorized disclosure transfer confidential information third party party agree that monetary damage sufficient remedy breach this article addition other remedy party shall entitled seek specific performance injunctive other equitable relief remedy breach threatened breach this article style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small small small small small ermination small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp term nbsp nbsp this agreement shall commence effective date unless terminated earlier provided this article mutual written agreement party shall continue until expiration last royalty term mtpc territory term upon expiration termination this agreement mtpc license under section nbsp will become perpetual irrevocable exclusive fully paid royalty free style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination cause style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp material breach nbsp nbsp each party shall have right terminate this agreement entirety upon written notice other party such other party materially breach this agreement cured such breach within with respect payment breach after notice such breach from breaching party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp bankruptcy nbsp nbsp each party shall have right terminate this agreement entirety upon written notice other party such other party make general assignment benefit creditor file insolvency petition bankruptcy petition acquiesces appointment receiver trustee similar officer liquidate conserve business substantial part asset commences under jurisdiction proceeding involving insolvency bankruptcy reorganization adjustment debt dissolution liquidation other similar proceeding release financially distressed debtor becomes party proceeding action type described above such proceeding dismissed within after commencement thereof style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination patent challenge neurocrine shall have right terminate this agreement entirety upon written notice mtpc mtpc affiliate sublicensees directly indirectly through third party commences interference opposition proceeding with respect challenge validity enforceability opposes extension grant supplementary protection certificate with respect neurocrine patent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination mtpc nbsp nbsp nbsp nbsp mtpc shall have right terminate this agreement time reason reason upon written notice neurocrine style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp effect termination certain situation nbsp nbsp nbsp nbsp upon termination this agreement neurocrine pursuant section nbsp termination this agreement mtpc pursuant following will apply style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp termination license other right license granted mtpc will automatically terminate other right obligation party under this agreement will terminate sublicenses under neurocrine technology granted from mtpc sublicensee will automatically terminate each case effective date termination provided however mtpc shall have fully paid perpetual license mtpc compound improvement invention style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp assignment nbsp nbsp neurocrine shall notify mtpc within after effective date termination whether wish obtain assignment forth section such assignment under section nbsp will without cost neurocrine style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp regulatory filing nbsp nbsp nbsp nbsp promptly practicable event within after such notice mtpc shall nbsp extent previously provided neurocrine deliver neurocrine true correct complete copy regulatory filing including regulatory approval product field mtpc territory provide neurocrine mtpc know previously disclosed neurocrine nbsp hereby effective upon such termination transfer assign cause transferred assigned neurocrine designee extent assignable take reasonable action make available neurocrine designee benefit regulatory filing including regulatory approval product field mtpc territory whether held name mtpc affiliate sublicensee nbsp take such other action execute such other instrument assignment document necessary effect evidence register record transfer assignment other conveyance right under this section nbsp neurocrine style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp mtpc technology nbsp nbsp mtpc shall hereby effective upon such termination assign neurocrine mtpc affiliate right title interest mtpc technology mtpc shall promptly take such action execute such instrument assignment document necessary effect evidence register record such assignment neurocrine cost style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp mark nbsp nbsp mtpc shall hereby effective such termination assign neurocrine mtpc affiliate right title interest product specific trademark used mtpc affiliate mtpc territory including goodwill therein mtpc shall promptly take such action execute such instrument assignment document necessary effect evidence register record such assignment neurocrine cost style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp wind down nbsp nbsp nbsp nbsp mtpc shall directed neurocrine either wind down ongoing development activity mtpc affiliate sublicensees with respect product field mtpc territory orderly fashion promptly transfer such development activity neurocrine designee compliance with applicable style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp transition assistance nbsp nbsp nbsp nbsp mtpc shall cost neurocrine provide reasonable consultation assistance period more than purpose transferring transitioning neurocrine mtpc know already neurocrine possession neurocrine request then existing commercial arrangement relating specifically compound product that mtpc able using commercially reasonable effort transfer transition neurocrine each case extent reasonably necessary useful neurocrine commence developing manufacturing commercializing product mtpc territory foregoing shall include transferring upon request neurocrine agreement with third party supplier vendor that specifically cover supply sale compound product mtpc territory such contract between mtpc third party assignable neurocrine whether such contract term because such contract relate specifically compound product otherwise reasonably necessary useful neurocrine commence developing manufacturing commercializing product mtpc territory mtpc manufacture product itself thus there contract assign then mtpc shall reasonably cooperate with neurocrine negotiate continuation service supply from such entity mtpc shall supply such compound product applicable neurocrine reasonable period exceed until neurocrine establishes alternate validated source such service supply finished packaged labeled product mtpc territory cost neurocrine such supply from mtpc shall mtpc cost style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp remaining inventory nbsp nbsp nbsp nbsp mtpc shall promptly deliver charge neurocrine inventory compound product held mtpc date termination that committed supplied third party sublicensee ordinary course business date termination price equal mtpc actual cost acquire manufacture such inventory style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp effect material breach neurocrine nbsp nbsp nbsp nbsp neurocrine materially breach this agreement cured such breach within after notice such breach from mtpc event breach that cured within implemented plan cure such breach within mtpc shall have right seek following remedy style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp case that mtpc will exercise right terminate this agreement pursuant section nbsp section nbsp nbsp will apply provided that neurocrine shall reimburse reasonable internal fully burdened rate external cost incurred mtpc conduct such activity under section nbsp notwithstanding anything contrary section nbsp style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp case that mtpc will exercise right terminate this agreement pursuant section nbsp this agreement shall survive remain full force effect except that mtpc withhold royalty payment obligation under section nbsp until such time neurocrine cured such breach implemented plan cure such breach case style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp confidential information nbsp nbsp nbsp nbsp upon termination this agreement entirety except extent that party obtains retains right other party confidential information each party shall promptly return other party delete destroy relevant record material such party possession control containing confidential information other party provided that such party keep copy such material archival purpose only subject continuing confidentiality obligation mtpc know assigned neurocrine after termination this agreement forth section nbsp will deemed neurocrine confidential information longer mtpc confidential information style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp survival nbsp nbsp expiration termination this agreement shall relieve party obligation right accruing prior such expiration termination except forth below elsewhere this agreement obligation right party under following provision this agreement shall survive expiration termination this agreement article section nbsp article section article section article section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp exercise right terminate nbsp nbsp either party hereto termination right provided under this agreement shall give rise payment damage other form compensation relief other party with respect thereto provided however that termination this agreement shall preclude either party from claiming other damage compensation relief that entitled upon such termination style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp damage relief nbsp nbsp subject section nbsp termination this agreement shall preclude either party from claiming other damage compensation relief that entitled upon such termination style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp right bankruptcy nbsp nbsp right license granted under pursuant this agreement party other party will otherwise deemed purpose section nbsp bankruptcy code comparable provision applicable bankruptcy insolvency license right intellectual property defined under section nbsp bankruptcy code comparable provision applicable bankruptcy insolvency party agree that party that licensee such right under this agreement will retain fully exercise right election under bankruptcy code comparable provision applicable bankruptcy insolvency party further agree that event commencement bankruptcy proceeding against party this agreement under bankruptcy code comparable provision applicable bankruptcy insolvency other party will entitled complete duplicate complete access appropriate such intellectual property embodiment such intellectual property same already possession will promptly delivered nbsp upon such commencement bankruptcy insolvency proceeding upon written request therefor unless bankrupt party elect continue perform obligation under this agreement nbsp delivered under nbsp above following rejection this agreement behalf bankrupt party upon written request therefor other party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small ispute small small esolution small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp objective party recognize that dispute matter nbsp arising under relating this agreement nbsp either party right obligation hereunder arise from time time objective party establish procedure facilitate resolution such dispute expedient manner mutual cooperation without resort litigation accomplish this objective party agree follow procedure forth this article nbsp resolve such dispute when arises style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp resolution executive officer except otherwise provided article unresolved dispute matter arising under relating this agreement either party right obligation hereunder arises either party refer such dispute executive officer shall meet person telephone within after such referral attempt good faith resolve such dispute such matter resolved discussion such officer within such period extended mutual written agreement such dispute shall resolved accordance with section style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp arbitration style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp party resolve dispute provided section nbsp party wish pursue matter each such dispute that excluded claim defined below shall resolved binding arbitration accordance with rule arbitration international chamber commerce then effect rule which rule deemed incorporated reference into this clause arbitration award rendered such arbitration will final appealable executed court competent jurisdiction either party intends commence binding arbitration such dispute such party will provide written notice other party informing other party such intention issue resolved within after receipt such notice other party written notice party initiating binding arbitration additional issue resolved style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp arbitration shall conducted panel three nbsp arbitrator appointed accordance with rule none whom shall current former employee director then current stockholder either party their respective affiliate sublicensee place arbitration shall honolulu hawaii proceeding communication shall english style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp intention party that discovery although permitted described herein will limited except exceptional circumstance arbitrator will permit such limited discovery necessary understanding legitimate issue raised arbitration including production document later than after selection arbitrator party their representative shall hold preliminary meeting with arbitrator mutually agree upon thereafter follow procedure seeking assure that arbitration will concluded within from such meeting failing such mutual agreement arbitrator will design party shall follow procedure such effect style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp either party apply arbitrator interim injunctive relief until arbitration award rendered controversy otherwise resolved either party also without waiving remedy under this agreement seek from court having jurisdiction injunctive provisional relief necessary protect right property that party pending arbitration award arbitrator shall have authority award punitive other compensatory damage except permitted section nbsp arbitrator shall have power order that part legal other cost incurred party connection with arbitration paid other party each party shall bear equal share arbitrator administrative arbitration style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp except extent necessary confirm enforce award required applicable neither party arbitrator disclose existence content result arbitration without prior written consent both party event shall arbitration initiated after date when commencement legal equitable proceeding based dispute controversy claim would barred applicable york statute limitation style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp used this section term excluded claim mean dispute controversy claim that concern nbsp validity enforceability infringement patent trademark copyright nbsp antitrust anti monopoly competition regulation whether statutory style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align justify style font family time roman font size small eneral small small rovisions small small small table style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp governing nbsp nbsp this agreement question regarding existence validity interpretation breach performance this agreement shall governed construed enforced accordance with state york united state without reference conflict principle with exception section york general obligation style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp entire agreement modification nbsp nbsp this agreement together with letter agreement supply agreement both final expression party agreement complete exclusive statement with respect term this agreement supersedes prior contemporaneous agreement communication whether oral written otherwise concerning matter contained herein this agreement only modified supplemented writing expressly stated such purpose signed party this agreement style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp relationship between party nbsp nbsp party relationship established this agreement solely that independent contractor this agreement create partnership joint venture similar business relationship between party neither party legal representative other party neither party assume create obligation representation warranty guarantee express implied behalf other party purpose whatsoever style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp waiver nbsp nbsp failure party insist upon strict performance provision this agreement exercise right arising this agreement shall neither impair that provision right constitute waiver that provision right whole part that instance other instance waiver party particular provision right shall writing shall particular matter applicable particular period time shall signed such party style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp assignment nbsp nbsp except expressly provided hereunder neither this agreement right obligation hereunder assigned otherwise transferred either party without prior written consent other party which consent shall unreasonably withheld provided however that either party assign otherwise transfer this agreement right obligation hereunder without other party consent style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp connection with transfer sale substantially business asset such party relating product third party whether merger consolidation divesture restructure sale stock sale asset otherwise provided that event such transaction whether this agreement actually assigned assumed acquiring party operation context reverse triangular merger intellectual property right acquiring party such transaction other than party this agreement shall included technology licensed hereunder style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp affiliate provided that assigning party shall remain liable responsible assigning party hereto performance observance such duty obligation such affiliate style margin margin bottom font size font family time roman align justify right obligation party under this agreement shall binding upon inure benefit successor permitted assigns party specified above name party appearing herein will deemed include name such party successor permitted assigns extent necessary carry intent this section assignment accordance with this section nbsp shall null void style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp severability nbsp nbsp reason part this agreement adjudicated invalid unenforceable illegal court competent jurisdiction such adjudication shall extent feasible affect impair whole part validity enforceability legality remaining portion this agreement remaining portion shall remain full force effect original agreement been executed without invalidated unenforceable illegal part style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp notice nbsp nbsp notice given under this agreement must writing delivered either person nbsp mail postage prepaid requiring return receipt nbsp overnight courier nbsp facsimile confirmed thereafter foregoing party notified address given below address such party designate prior written notice other accordance with this section nbsp notice shall deemed sufficiently given purpose upon earliest nbsp date actual receipt nbsp mailed five nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align justify after date postmark nbsp delivered overnight courier next overnight courier regularly make delivery nbsp sent facsimile date confirmation receipt during recipient normal business hour otherwise next business style margin margin bottom text indent font size font family time roman align justify mtpc notice must addressed style margin margin bottom text indent font size font family time roman align justify mitsubishi tanabe pharma corporation style margin margin bottom text indent font size font family time roman align justify dosho machi chuo style margin margin bottom text indent font size font family time roman align justify osaka style margin margin bottom text indent font size font family time roman align justify japan style margin margin bottom text indent font size font family time roman align justify attention nbsp nbsp general manager style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp global product strategy department style margin margin bottom text indent font size font family time roman align justify facsimile style margin margin bottom text indent font size font family time roman align justify with copy style margin margin bottom text indent font size font family time roman align justify mitsubishi tanabe pharma corporation style margin margin bottom text indent font size font family time roman align justify dosho machi chuo style margin margin bottom text indent font size font family time roman align justify osaka style margin margin bottom text indent font size font family time roman align justify japan style margin margin bottom text indent font size font family time roman align justify attention general manager style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp legal affair nbsp intellectual property department style margin margin bottom text indent font size font family time roman align justify facsimile style margin margin bottom text indent font size font family time roman align justify neurocrine notice must addressed style margin margin bottom text indent font size font family time roman align justify neurocrine bioscience style margin margin bottom text indent font size font family time roman align justify camino real style margin margin bottom text indent font size font family time roman align justify diego style margin margin bottom text indent font size font family time roman align justify style margin margin bottom text indent font size font family time roman align justify attention chief executive officer style margin margin bottom text indent font size font family time roman align justify facsimile style margin margin bottom text indent font size font family time roman align justify with copy style margin margin bottom text indent font size font family time roman align justify neurocrine bioscience style margin margin bottom text indent font size font family time roman align justify camino real style margin margin bottom text indent font size font family time roman align justify diego style margin margin bottom text indent font size font family time roman align justify style margin margin bottom text indent font size font family time roman align justify attention chief legal officer style margin margin bottom text indent font size font family time roman align justify facsimile style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp force majeure each party shall excused from liability failure delay performance obligation under this agreement other than failure make payment when reason event beyond such party reasonable control including limited fire flood explosion earthquake pandemic other natural force civil unrest terrorism accident destruction other casualty lack failure transportation facility lack failure supply material other event similar those enumerated above such excuse from liability shall effective only extent duration event causing failure delay performance provided that party caused such event occur notice party failure delay performance force majeure must given other party within after occurrence delivery date under this agreement that have been affected force majeure shall tolled duration such force majeure event shall party required prevent settle labor disturbance dispute style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp interpretation heading clause contained this agreement preceding text section subsection paragraph hereof inserted solely convenience ease reference only shall constitute part this agreement have effect interpretation construction reference this agreement singular shall include plural where applicable unless otherwise specified reference this agreement article shall include section subsection paragraph such article reference section shall include subsection paragraph such section reference this agreement subsection shall include paragraph such subsection word including similar word mean including without limitation word mean unless context dictate otherwise because subject conjunction mutually exclusive word herein hereof hereunder other word similar import refer this agreement whole particular section other subdivision reference this agreement mean calendar unless otherwise specified ambiguity uncertainty this agreement shall interpreted against either party irrespective which party deemed have caused ambiguity uncertainty exist this agreement been prepared english language english language shall control interpretation addition notice required permitted given hereunder written electronic oral other communication between party regarding this agreement shall english language style margin margin bottom text indent font size font family time roman align justify nbsp nbsp nbsp nbsp nbsp nbsp counterpart electronic facsimile signature this agreement executed number counterpart each which shall original which together shall constitute instrument this agreement executed delivered electronically facsimile upon such delivery such electronic facsimile signature will deemed have same effect original signature been delivered other party style margin margin bottom font size font family time roman align center small ignature small small small small ollows small style margin margin bottom font size font family time roman align right confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman align justify small small small itness small small hereof small small small party hereto have caused this small ollaboration small small small small icense small small greement small small small executed entered into their duly authorized representative effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan small eurocrine small small iosciences small small small valign bottom valign valign bottom valign colspan small itsubishi small small anabe small small harma small small orporation small small small style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign nbsp kevin nbsp nbsp gorman nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp valign bottom valign valign bottom valign valign bottom valign masayuki mitsuka nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size height colspan height colspan height colspan style font family time roman font size valign colspan name nbsp kevin nbsp nbsp gorman nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp valign bottom valign valign bottom valign colspan name nbsp masayuki nbsp mitsuka nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size height colspan height colspan height colspan style font family time roman font size valign colspan title nbsp nbsp president chief executive officer valign bottom valign valign bottom valign colspan title nbsp nbsp president nbsp nbsp representative nbsp director nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign valign bottom valign valign bottom valign valign bottom valign bottom style margin left font size font family time roman chief executive officer table style margin margin bottom font size font family time roman align center small ignature small small small small small small ollaboration small small small small icense small small greement small body html text document